Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03293745 · ClinicalTrials.gov registry record · NA
Cognitive Behavioral Therapy for Insomnia: Face-to-Face Versus Telemedicine
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
NCT03293745: Completed NA study, sponsored by University of Michigan.
NCT03293745 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 65 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03293745, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness of Cognitive-Behavioral Therapy (CBT) for insomnia conducted face-to-face with a therapist versus CBT for insomnia conducted using Internet-based videoconference technology.
Primary Outcome
The ISI is a 7-item questionnaire assessing the nature, severity, and impact of sleep problems, with good psychometric properties and sensitivity to change with treatment 0-7 = No clinically significant insomnia 8-14 = Subthreshold insomnia 15-21 = Clinical insomnia (moderate severity) 22-28 = Clinical insomnia (severe)
Interventions
- BEHAVIORAL Face to Face CBT-I (F2F)
- BEHAVIORAL Telemedicine CBT-I (TM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2017-11-15 |
| Est. Completion | 2019-10-04 |
| Phase | NA |
What the finished NCT03293745 record still lists
NCT03293745 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Face to Face CBT-I (F2F) is the first listed.
NCT03293745 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03293745 about?
NCT03293745 is a clinical study titled "Cognitive Behavioral Therapy for Insomnia: Face-to-Face Versus Telemedicine". The purpose of this study is to compare the effectiveness of Cognitive-Behavioral Therapy (CBT) for insomnia conducted face-to-face with a therapist versus CBT for insomnia conducted using Internet-based videoconference technology.
What is the current status of trial NCT03293745?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2017-11-15. Estimated completion is 2019-10-04.
What interventions are being tested in trial NCT03293745?
The interventions under investigation include: Face to Face CBT-I (F2F) (BEHAVIORAL), Telemedicine CBT-I (TM) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03293745?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03293745's enrollment target sits among peer trials
65 1144th of 2000 higher than 854 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI